Behavioral Health AI
J

Jimini Health

Jimini Health sells Sage, an AI behavioral health assistant that works with patients between therapy sessions under the direction of their own clinician. A participating provider invites the patient and sets goals and priorities, and Sage uses them to guide check ins, reflection, skill practice and reminders tied to the care plan, then shares progress with the therapist in the Jimini Therapist Portal. Separate classifiers read each conversation in parallel for signs of risk and alert the care team, which decides what to do, and Sage is positioned as a member of the care team, never a substitute for a clinician.

The risk classifiers were built with clinicians and tested on synthetic therapy conversations annotated by PhD level clinicians blind to the model's predictions. New capabilities roll out in stages, from review of every output by the clinical safety team within 24 to 48 hours, to sampled review, to review triggered by flags from patients, therapists or automated monitoring.

Jimini sells to behavioral health provider organizations, including multisite groups with virtual and in person care, with implementations that cover clinician training, configuration and record integration. Luis Voloch is chief executive, Bill Hudenko chief clinical officer and Johannes Eichstaedt chief scientist. Based in New York, the company raised a $17 million seed round in March 2026 from investors including M13, Town Hall Ventures and LionBird, bringing total funding past $25 million.

AI Health Index verifiedNovember 20, 2026
Compare Jimini Health with other vendors
Founded
—
Headquarters
New York, New York, US
Categories
behavioral-health
Indexed Products
Sage, Jimini Therapist Portal
Buyer Segments
Behavioral Health Provider, Behavioral Health Clinic, Health System
Assessment

Capability Axes

An AI Health Index grade measures what a buyer can verify from public sources on the date shown. It is not a rating of how good the product is. A vendor can build an excellent system and grade low on an axis because it publishes nothing an outsider can check. How grades read

AI Capability
AA on AI CentralityThe artificial intelligence is the product. Remove the model and there is nothing left to sell.
Vendor Published

Sage holds conversations shaped by the treating clinician's goals and instructions, prompting a patient to reflect, practice a skill or report progress between visits, and separate classifiers read each message for signs that the care team should look at the conversation. Clinicians see what matters through the portal.

Reminders and tracking sit around the conversation, but the conversation itself and the decision about what reaches a clinician are model work, and without the language models and classifiers little of the service would remain.

BB on Autonomy and Oversight ModelThe oversight structure is described and one part is missing, commonly the threshold at which the system stops or what happens after it is wrong.
Vendor Published

Clinicians set the goals and activities Sage supports between appointments, and patients get conversational responses directly, with rules separating routine exchanges from events that need provider review. When a concern is flagged, Sage can gather more context and alerts the therapist or care team through the portal, and the care team decides the response.

New capabilities start under full supervision, with every output reviewed by the clinical safety team within 24 to 48 hours, before moving to sampled and targeted review. No response time is guaranteed for an escalation, and no override process is defined for each kind across participating organizations.

BB on Model and Technology TransparencyThe approach or the suppliers are named without the version and update discipline behind them. Naming a supplier is the entry to this band both here and on Model Supply Chain Disclosure, which ask different questions of the same disclosure: who receives the data, and what produces the output.
Vendor Published

Sage pairs a conversational language model with several risk classifiers that analyze messages in parallel, so no single assistant response decides which interactions reach a clinician. The classifiers were fine tuned on synthetic therapy conversations generated by frontier models and evaluated against a clinician annotated reference set, and the framework names each model's role and puts changes through staged review. No foundation model or version is named for the current service, and no release history exists for each classifier.

CC on Model Supply Chain DisclosureThe architecture is described and no model provider is named. Naming a hosting provider alone does not lift a record out of this band. Record the host in the note, because it matters for residency and breach scope, and grade on the model layer, which is the question this axis is named for.
Vendor Published

The conversational AI and the classifiers are separate components of Sage, and development used outside frontier models, none named, to synthesize test conversations, which says nothing about who processes live patient messages. The privacy policy lets outside companies provide hosting, analytics, support and other operations under contractual limits but names no supplier for the conversational model or the live classifiers. Processing regions, retention at each model supplier and the firms receiving inputs under provider agreements are unknown for the deployed service.

DD on Clinical and Operational EvidenceNo named deployment and no performance claim a reader can check. A figure published with no source sits here rather than higher.
Vendor Published

Sage's evidence so far is a safety framework rather than a result. Its risk classifiers were fine tuned on synthetic therapy conversations generated by frontier models, and PhD level clinicians, blind to the model's predictions, annotated a gold standard set to test them, but the framework reports no recall, precision or false negative rate and calls the classifier high accuracy without a figure.

No provider organization is named as a customer, the March 2026 funding release says Jimini will look to partner with large behavioral health providers, and no patient outcome, symptom change or deployment count exists for the current service.

CC on AI Safety and PHI StewardshipGeneral assurances of privacy and security that do not answer the questions artificial intelligence raises: what is retained, what reaches a model, and what happens to it there.
Vendor Published

Jimini's privacy policy permits using personal data outside its protected health information carveout for model training and analytics, while clinical material processed for providers falls under a separate business associate arrangement. Other information is kept for its stated purposes, with some copies remaining in backups or for legal reasons after an account closes. Sage runs parallel safety checks, structured alerts and human follow up on flagged events. No fixed retention period covers patient conversations, and no stated term bars training on conversations governed by a business associate agreement.

Regulatory and Compliance
BB on HIPAA and BAA PostureBusiness associate status is stated and supported by a substantive privacy document, with the agreement or its scope not fully published. For a vendor outside the United States, an equivalent regime documented to this depth grades here. A vendor whose product does not process protected health information grades here too when it says so plainly and explains the scope, with a service privacy document behind it: stating a position a buyer can rely on is the posture this axis grades, and the band above is closed to it because there is no agreement to publish.
Vendor Published

Jimini contracts with the licensed clinician or organization that invites a patient to handle protected health information as a business associate, and separates clinical information governed by those agreements from other personal data under its general policy. Provider teams review patient progress through the portal as part of care, and the general policy binds service providers receiving personal data to confidentiality. The agreement itself cannot be read before contracting, so its subcontractor obligations and any tiers for the clinical service are unknown.

DD on Security Certifications and Trust CenterControls are asserted with nothing independent behind them, or nothing is published. Read the note before concluding anything: this is the grade most often corrected on a second pass, because assurance material frequently sits on a parent domain or inside an old announcement rather than on the product pages.
Vendor Published

Patients join through a participating provider and sign in to the app, partners handling personal data are bound to confidentiality and limited operational purposes, and the provider's agreement governs health information processed under HIPAA. The terms separate routine electronic communications, which may be unencrypted, from clinical handling in the service. Sage is described only as secure and privacy protected, and no SOC 2, HITRUST or ISO audit report states a scope and period for it.

CC on FDA and Regulatory StatusNo device claim is made and the product is scoped accordingly. Most administrative and operational products sit here and are not penalized for it, because this axis grades the appropriateness of the positioning rather than possession of a clearance. A stated limit on use, such as research use only or a clause that the product gives no medical advice, beside marketing that sells the product for clinical decisions also sits here, with both quoted, because the buyer has to ask which one governs.
Vendor Published

The patient app presents activities and exercises aligned with the treating provider's recommendations, and its terms leave diagnosis and treatment decisions with the licensed provider. Sage also talks with patients between visits and uses risk classifiers to decide when an interaction needs the care team, which reviews the alert and acts on it. No FDA clearance or named regulatory exclusion covers that risk classification, and the only regulatory position offered is a general line that Sage complies with federal and state regulations.

BB on AI Governance and Bias DisclosureA governance framework with named process behind it, such as certification to an artificial intelligence management standard, or material written for a customer own review committee to evaluate the product with. A framework covering the vendor whole portfolio counts when its scope reaches this product; what it cannot supply is the product specific evaluation the band above asks for. Published results within the one group where the performance of this product is most at risk also sit here: evaluation on the question this axis asks, short of the comparison across groups the band above requires. A medical device clearance or certification, and the quality system behind it, does not reach this band on its own; it is graded under regulatory status. A regulator reviewed plan governing how the model may change does reach it.
Vendor Published

Jimini's clinical safety framework puts each new behavior through validation and red teaming, then staged release under clinician review. Evaluation uses simulated conversations labeled by clinicians blind to the model's predictions, and later monitoring samples interactions or prioritizes those flagged by patients, therapists or automated checks, with AI judges helping order the review queue. Its measures cover alignment with therapist priorities, safety and tone. No independent audit covers the deployed models, and no results compare risk detection across demographics, dialects, languages or care settings.

CC on AI Liability and RecourseMechanisms exist that let someone challenge an output, such as audit trails, source traceability or review before commit, with nothing standing behind the output and no route for the harmed party.
Vendor Published

Clinicians can inspect alerts and follow up on a conversation in the therapist portal. Patients can also raise concerns with their provider or contact Jimini support. The patient terms require an informal dispute attempt before most formal proceedings, and generally cap aggregate liability at the greater of $100 or amounts paid in the preceding six months, subject to applicable law. The terms disclaim warranties on output and address harms related to provider action. There is no commitment to correct a harmful generated response or compensate a patient for a missed escalation.

Integration and Deployment
DD on EHR and Interoperability DepthNo integration evidence. A connector described as available on request grades here until one exists.
Vendor Published

Providers set goals and follow patient interactions through the Jimini Therapist Portal, and patients use a separate mobile app. Implementation work can include connecting a provider organization's electronic record, though no record system is named, and no FHIR interface or production exchange is described. Sage is not shown retrieving a patient chart or writing clinician reviewed plans back into one, so the portal remains the only place clinicians see its output.

CC on Deployment Model and Data ResidencyA single hosted option with location implied rather than committed.
Vendor Published

Patients use the mobile app after a provider invitation, clinicians use the portal, and Jimini coordinates implementation with each provider organization. The standard terms limit the app to people in the United States, and the privacy terms let outside firms help with hosting, technical support and other operations.

United States availability implies rather than commits where messages are stored and processed, and there is no named region, customer hosted version or description of how one provider's clinical data is isolated from another's.

Commercial
CC on Commercial TransparencyNo price is published and the posture is discoverable: a buyer can establish how the product is sold and what drives the cost before contacting the vendor. Most of the index sits here.
Vendor Published

Behavioral health provider organizations buy Sage through a commercial engagement, and patients already in care join by invitation from a participating provider. The implementation is built for organizations with several sites or a mix of virtual and in person care and can include clinician training, provider configuration and record integration, with Lynn Hamilton, formerly chief commercial officer at Talkspace, leading commercial work. No price per patient or clinician, usage allowance or plan is stated for the enterprise implementation.

CC on Setting and Specialty CoverageCoverage is claimed broadly without specifics, or stated clearly with nothing validating it yet.
Vendor Published

Sage serves behavioral health organizations and focuses on care between appointments: exercises aligned with a therapist's instructions, reminders and progress reflection for patients seen in person, virtually or in hybrid programs, with providers deciding how their sites and clinicians take part.

The classifier evaluation used simulated behavioral health scenarios and measured nothing by diagnosis, age or level of care, and no named deployment validates the service across outpatient settings or the more complex programs Jimini aims to serve.

Alternatives

Alternatives to Jimini Health

Other products that do the same kind of work as Jimini Health, and what each one does.

AI that measures the quality of psychotherapy and counseling rather than documenting it.

Behavioral health integration infrastructure sold to risk bearing organizations, health systems and health plans rather than to patients.

TheraPro is an AI note writer for therapists from TheraPro AI, Inc., a Layton, Utah company incubated by the software firm Novosi.

Blueprint, from HelloJoy, Inc., is an AI assistant and electronic health record for mental health therapists.

Aiberry sells anonymous mental health screening to organizations, positioned as a digital front door to care rather than as care.

TheraPulse is a small ambient documentation tool for mental health clinicians, producing progress notes and summaries in about a minute in SOAP, DAP and BIRP formats, alongside session summaries, client progress tracking and session insights.

Commercial

Pricing

Vendor-published figures are labeled as such. Figures labeled “Estimated” are derived from third-party sources and have not been confirmed by the vendor.

Entry Price Pricing Basis BAA Tier Implementation Source
Enterprise quote
Behavioral health organizations purchase Sage through an enterprise engagement. The implementation is configured for their care teams and sites. No standard price per patient or clinician is available. Jimini acts as a business associate for clinical providers and organizations. The signed agreement governs clinical data. The implementation can include clinician training, workflow configuration and electronic record integration. Fees depend on the provider agreement. Vendor Published

Patients access Sage by invitation from a participating clinician or care organization. Enterprise pricing and setup are handled through the provider relationship.